HIV-1感染症(HIV-1 Infection):世界の治験レビュー(2014年下半期版)

◆英語タイトル:HIV-1 Infection Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2454CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:164
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるHIV-1感染症(HIV-1 Infection) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - HIV-1感染症(HIV-1 Infection)
  - 当レポートの概要
・HIV-1感染症(HIV-1 Infection):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

HIV-1 Infection Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “HIV-1 Infection Global Clinical Trials Review, H2, 2014″ provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
HIV-1 Infection 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of HIV-1 Infection 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in HIV-1 Infection Therapeutics Clinical Trials 37
Prominent Drugs 38
Latest Clinical Trials News on HIV-1 Infection 39
Nov 11, 2014: AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting 2014 39
Nov 03, 2014: Merck Announces Data from 48-Week Phase 2b Study of Investigational HIV Therapy Doravirine (MK-1439) in Treatment-Naive Patients 40
Oct 13, 2014: CytoDyn Announces 100% Success With PRO 140 in Four-Week Monotherapy Clinical Trial 41
Sep 24, 2014: Gilead’s Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies 42
Clinical Trial Profiles 44
Clinical Trial Overview of Top Companies 44
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Gilead Sciences, Inc. 54
Clinical Trial Overview of Gilead Sciences, Inc. 54
Merck & Co., Inc. 61
Clinical Trial Overview of Merck & Co., Inc. 61
C. H. Boehringer Sohn AG & Co. KG 66
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 66
Pfizer Inc. 70
Clinical Trial Overview of Pfizer Inc. 70
F. Hoffmann-La Roche Ltd. 74
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 74
Johnson & Johnson 78
Clinical Trial Overview of Johnson & Johnson 78
Bristol-Myers Squibb Company 82
Clinical Trial Overview of Bristol-Myers Squibb Company 82
Abbott Laboratories 85
Clinical Trial Overview of Abbott Laboratories 85
Janssen R&D Ireland 87
Clinical Trial Overview of Janssen R&D Ireland 87
Clinical Trial Overview of Top Institutes / Government 89
The National Institute of Allergy and Infectious Diseases 89
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 89
French National Agency for Research on AIDS and Viral Hepatitis 100
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 100
AIDS Clinical Trials Group 103
Clinical Trial Overview of AIDS Clinical Trials Group 103
University of California, San Francisco 105
Clinical Trial Overview of University of California, San Francisco 105
Hospital Clinic de Barcelona 106
Clinical Trial Overview of Hospital Clinic de Barcelona 106
University of Washington 107
Clinical Trial Overview of University of Washington 107
Imperial College London 108
Clinical Trial Overview of Imperial College London 108
University of North Carolina 109
Clinical Trial Overview of University of North Carolina 109
International Partnership For Microbicides 110
Clinical Trial Overview of International Partnership For Microbicides 110
Medical Research Council 111
Clinical Trial Overview of Medical Research Council 111
Five Key Clinical Profiles 112
Appendix 162
Abbreviations 162
Definitions 162
Research Methodology 163
Secondary Research 163
About GlobalData 164
Contact Us 164
Disclaimer 164
Source 164

List of Tables
HIV-1 Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7
HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 21
HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
HIV-1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014* 25
HIV-1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
HIV-1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014* 28
HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 35
HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 44
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 54
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 61
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 66
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 70
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 74
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 78
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 82
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 85
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen R&D Ireland, 2014* 87
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 89
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 100
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2014* 103
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 105
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2014* 106
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 107
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 108
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2014* 109
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by International Partnership For Microbicides, 2014* 110
HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014* 111

List of Figures
HIV-1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 35
HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
GlobalData Methodology 163

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[HIV-1感染症(HIV-1 Infection):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆